Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
generic
Amazon Launches $5-a-Month Prescription Drug Plan in Further Healthcare Push
The new Prime membership benefit, dubbed RxPass, will offer unlimited access to commonly prescribed generic medications. Source link
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion
The proposed settlement is the latest move by a company seeking to resolve the costly litigation. Under the terms, the...
Biogen to Sell Biosimilar-Venture Stake to Partner Samsung Biologics
Biogen Inc. is selling its share in biosimilar joint venture Samsung Bioepis for at least $2.25 billion to partner Samsung...
Teva Found Liable for Fueling Opioid Addiction in New York
A jury in New York state found drugmaker Teva Pharmaceuticals Industries Ltd. liable for creating a public nuisance in the...
Drugmakers Accused of Causing Opioid Addiction in Trial
A lawyer for several large California communities accused four drugmakers of causing a deadly wave of opioid addiction with their...
